Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
955
-
Total 13F shares, excl. options
-
213M
-
Shares change
-
+368K
-
Total reported value, excl. options
-
$89.8B
-
Value change
-
+$221M
-
Put/Call ratio
-
1.8
-
Number of buys
-
450
-
Number of sells
-
-403
-
Price
-
$422.24
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2015
1,056 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2015.
BIOGEN INC. - Common Stock (BIIB) has 955 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 213M shares
.
Largest 10 shareholders include FMR LLC (22M shares), PRIMECAP MANAGEMENT CO/CA/ (16.6M shares), VANGUARD GROUP INC (13.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.8M shares), STATE STREET CORP (9.79M shares), Clearbridge Investments, LLC (8.03M shares), BlackRock Institutional Trust Company, N.A. (6.22M shares), JPMORGAN CHASE & CO (5.85M shares), JENNISON ASSOCIATES LLC (5.1M shares), and SANDS CAPITAL MANAGEMENT, LLC (5.01M shares).
This table shows the top 955 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.